 | Up a level |
Verardi, Fabio; Maul, Lara Valeska; Borsky, Kim; Steinmann, Simona; Rosset, Nina; Pons, Hector Ortega; Sorbe, Christina; Yawalkar, Nikhil; Micheroli, Raphael; Egeberg, Alexander; Thyssen, Jacob P; Heidemeyer, Kristine; Boehncke, Wolf-Henning; Conrad, Curdin; Cozzio, Antonio; Pinter, Andreas; Kündig, Thomas; Navarini, Alexander A; Maul, Julia-Tatjana (2024). Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT). Journal of the European Academy of Dermatology and Venereology : JEADV, 38(4), pp. 719-731. Wiley 10.1111/jdv.19730
van Huizen, Astrid M; Menting, Stef P; Gyulai, Rolland; Iversen, Lars; van der Kraaij, Gayle E; Middelkamp-Hup, Maritza A; Warren, Richard B; Spuls, Phyllis I; Schejtman, Adrián A; Egeberg, Alexander; Firooz, Alireza; Kumar, Alur S; Oakley, Amanda; Foulkes, Amy; Ramos, Andrea Machado Coelho; Fougerousse, Anne-Claire; Carija, Antoanela; Akman-Karakas, Ayse; Horváth, Barbara; Fábos, Béata; ... (2022). International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis. JAMA dermatology, 158(5), pp. 561-572. American Medical Association 10.1001/jamadermatol.2022.0434
Zwicky, Pascale; Ingelfinger, Florian; Silva de Melo, Bruno Marcel; Ruchti, Fiorella; Schärli, Stefanie; Puertas, Nicole; Lutz, Mirjam; Phan, Truong San; Kündig, Thomas M; Levesque, Mitchell P; Maul, Julia-Tatjana; Schlapbach, Christoph; LeibundGut-Landmann, Salomé; Mundt, Sarah; Becher, Burkhard (2021). IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation. Science immunology, 6(64), eabg9012. American Association for the Advancement of Science 10.1126/sciimmunol.abg9012
Maul, Julia-Tatjana; Anzengruber, Florian; Conrad, Curdin; Cozzio, Antonio; Häusermann, Peter; Jalili, Ahmad; Kolios, Antonios G A; Laffitte, Emmanuel; Lapointe, Anne-Karine; Mainetti, Carlo; Schlapbach, Christoph; Trüeb, Ralph; Yawalkar, Nikhil; Dippel, Michaela; Navarini, Alexander A (2021). Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology, 237(2), pp. 166-178. Karger 10.1159/000512930
Drach, Mathias; Papageorgiou, Karolina; Maul, Julia-Tatjana; Djamei, Vahid; Yawalkar, Nikhil; Häusermann, Peter; Anzengruber, Florian; Navarini, Alexander A (2019). Effectiveness of methotrexate in moderate to severe psoriasis patients: real-world registry data from the Swiss Dermatology Network for Targeted Therapies (SDNTT). Archives of dermatological research, 311(10), pp. 753-760. Springer 10.1007/s00403-019-01945-6
Anzengruber, Florian; Augustin, Matthias; Radtke, Marc A; Thaci, Diamant; Yawalkar, Nikhil; Streit, Markus; Reich, Kristian; Drach, Mathias; Sorbe, Christina; French, Lars E; Mrowietz, Ulrich; Maul, Julia-Tatjana; Itin, Peter H; Navarini, Alexander A (2019). Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional Study. Acta dermato-venereologica, 99(10), pp. 871-877. Society for the Publication of the Acta dermato-venereologica 10.2340/00015555-3221
Maul, Julia-Tatjana; Djamei, Vahid; Kolios, Antonios G A; Meier, Barbara; Czernielewski, Justine; Jungo, Pascal; Yawalkar, Nikhil; Mainetti, Carlo; Laffitte, Emmanuel; Spehr, Christina; Anliker, Mark; Streit, Markus; Augustin, Matthias; Rustenbach, Stephan; Conrad, Curdin; Hafner, Jürg; Boehncke, Wolf-Henning; Borradori, Luca; Gilliet, Michel; Itin, Peter; ... (2016). Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT. Dermatology, 232(6), pp. 640-647. Karger 10.1159/000452740
Jungo, Pierre; Maul, Julia-Tatjana; Djamei, Vahid; von Felten, Stefanie; Kolios, Antonios G A; Czernielewsk, Justine; Yawalkar, Nikhil; Odermatt, Olivia; Laffitte, Emmanuel; Anliker, Mark; Streit, Markus; Augustin, Matthias; Conrad, Curdin; Hafner, Jürg; Boehncke, Wolf-Henning; Gilliet, Michel; Itin, Peter; French, Lars E; Navarini, Alexander A and Häusermann, Peter (2016). Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry. Dermatology, 232(6), pp. 655-663. Karger 10.1159/000455042
